武俊紫，男，1986年10月，他是吕梁学院生物与食品工程系生物科学专业2011届毕业生，现就职于云南中医药大学，2025年4月获得云南中医药大学博士研究生导师资格。从吕梁学院到更广阔的舞台，他用奋斗诠释了吕院人的精神底色。

吕院印记，终身成长。在校期间，武俊紫始终秉持“弘毅行知”校训，勤奋刻苦、锐意进取，打下了坚实的专业基础。回顾大学时光，武俊紫对母校充满感激：“吕梁学院为我提供了个性化发展空间，实习实训、学术讲座等活动拓宽了我的视野，老师和同窗的鼓励让我始终充满动力。”

以勤为径，厚积薄发。工作5年以来，第一作者发表论文30余篇，其中SCI论文10余篇。现主持国家自然科学基金《中药2-苯基色原酮结构单体作为缓释辅料构建的纳米粒子在糖尿病中的应用及其机制研究》一项，云南省自然科学基金《基于“从瘀而论”血小板活化因子在银杏内酯B治疗非酒精性脂肪肝病的作用》一项，云南省科技计划项目《中药紫檀芪和3-丙烯酰胺基苯硼酸共聚的纳米胰岛素药物载体构建及其对糖尿病大鼠的作用研究》1项。担任SCI期刊《Journal of Cluster Science》《Anti-Cancer Agents in Medicinal Chemistry》编委。

传承吕院精神，砥砺前行。如今，武俊紫在自己的工作岗位继续深耕，他表示：“无论走到哪里，“弘毅行知"的校训始终鞭策我脚踏实地、敢于担当。希望学弟学妹们珍惜吕院的每一寸光阴，勇敢追逐热爱之事！”

吕梁学院始终坚持以学生为中心，培养具有家国情怀、创新精神和社会责任感的高素质应用型人才。武俊紫的成长轨迹是万千吕院学子的缩影，未来，更多“武俊紫”将从这里出发，书写新时代青年的奋进篇章！

主要论文：

1) Sen Tong, Shicui Luo, Qiuqiong Yang, Bo Song, Renjie Chang, Junzi Wu*. Preparation and biological evaluation of a glucose-responsive block copolymer nanoparticle with the ability to ameliorate diabetic kidney damage[J]. European Polymer Journal, 2024: 113472.

2) Yilu Zheng, Yichao Du, Gareth R. Williams, Ying Zhu, Tong Wang, Yanyan Zhang, Jinxing Xu , Junzi Wu*, Fan Li, Li-Min Zhu. A piezoelectric catalytic cascade nanoreactor which reshapes the tumor microenvironment and promotes effective multi-dimensional therapy[J]. Nano Energy, 2024, 126: 109598.

3) Liying Huang, Shicui Luo, Sen Tong, Zhuo Lv, Junzi Wu*. The development of nanocarriers for natural products[J]. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2024, 16(3): e1967.

4) Huanhuan Zhao, Yan Li, Jiaxin Chen, Jinjia Zhang, Qiuqiong Yang, Ji Cui, Anhua Shi, Junzi Wu*. Environmental stimulus-responsive mesoporous silica nanoparticles as anticancer drug delivery platforms[J]. Colloids and Surfaces B: Biointerfaces, 2024: 113758.

5)  Qiaoyan Liu , Bo Song , Sen Tong , Qiuqiong Yang , Huanhuan Zhao, Jia Guo , Xuexia Tian , Renjie Chang, Junzi Wu*. Research Progress on the Anticancer Activity of Plant Polysaccharides [J]. Recent Pat Anticancer Drug Discov, 2024, 19(5): 573-98.

6) Rong Ren, David H. Bremner, Wenling Chen, Anhua Shi, Tong Wang, Ying Wang, Chengji Wang, Junzi Wu*, Li-Min Zhu. A multifunctional nanocomposite coated with a BSA membrane for cascaded nitric oxide therapy[J]. International journal of biological macromolecules, 2023, 238: 124087.

7) Shicui Luo, Zhuo Lv, Qiuqiong Yang, Renjie Chang, Junzi Wu*. Research progress on stimulus-responsive polymer nanocarriers for cancer treatment[J]. Pharmaceutics, 2023, 15(7): 1928.

8) Jia Guo, Zheng Yao, Feiyu Zhang, Junzi Wu*. Application of Polymer Materials in Targeting Glioma [J]. Anticancer Agents Med Chem, 2023, 23(11): 1284-97.

9) Qiong Ma, Ligong Bian, Xi Zhao, Xuexia Tian, Hang Yin, Yutian Wang, Anhua Shi, Junzi Wu*. Novel glucose-responsive nanoparticles based on p-hydroxyphenethyl anisate and 3-acrylamidophenylboronic acid reduce blood glucose and ameliorate diabetic nephropathy[J]. Materials Today Bio, 2022, 13: 100181.

10) Sen Tong, Qingyu Li, Qiaoyan Liu, Bo Song, Junzi Wu*. Recent advances of the nanocomposite hydrogel as a local drug delivery for diabetic ulcers[J]. Frontiers in Bioengineering and Biotechnology, 2022, 10: 1039495.

11) Xuexia Tian, Anhua Shi, Hang Yin, Yutian Wang, Qiaoyan Liu, Wenling Chen, Junzi Wu*. Nanomaterials respond to lysosomal function for tumor treatment[J]. Cells, 2022, 11(21): 3348.

12) Yutian Wang, Junzi Wu*, Anhua Shi. Literature Review on the Use of Herbal Extracts in the Treatment of Non- Alcoholic Fatty Liver Disease [J]. Endocr Metab Immune Disord Drug Targets, 2022, 22(11): 1123-45.

13) Xuexia Tian, Anhua Shi, Junzi Wu*. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting [J]. Anticancer Agents Med Chem, 2022, 22(12): 2255-73.

14) Hang Yin, Anhua Shi, Junzi Wu*. Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease [J]. Diabetes Metab Syndr Obes, 2022, 15: 2003-30.

15) Jing Yang , Bo Song, Junzi Wu*. Herbal Nanoformulations for Asthma Treatment [J]. Curr Pharm Des, 2022, 28(1): 46-57.

16) Qiong Ma, Xi Zhao, Anhua Shi, Junzi Wu*. Bioresponsive functional phenylboronic acid-based delivery system as an emerging platform for diabetic therapy[J]. International Journal of Nanomedicine, 2021: 297-314.

17) Xi Zhao, Anhua Shi, Qiong Ma, Xueyan Yan, Ligong Bian, Pengyue Zhang, Junzi Wu*. Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications[J]. Journal of Nanobiotechnology, 2021, 19: 1-18.

18) Pengyue Zhang, Qiong Ma, Dan He, Guohua Liu, DiWei Tang, Lu Liu, Junzi Wu*. A new Glucose-Responsive delivery system based on Sulfonamide-phenylboronic acid for subcutaneous insulin injection[J]. European Polymer Journal, 2021, 157: 110648.

19) Dexia Luo, Zheng Yao,Junzi Wu*. Polymers Based on Phenyl Boric Acid in Tumor-Targeted Therapy [J]. Anticancer Agents Med Chem, 2021, 21(17): 2288-96.

科研项目